Infographic | September 18, 2025

Every Completed Trial, Every Emerging Trend

Source: Citeline
GettyImages-2095562171-data-tech-network

Clinical research is undergoing a significant transformation, with a faster pace of completed trials and an increased focus on patient-centricity and operational efficiency. The number of industry-sponsored clinical studies completed in 2024 saw a remarkable 14.2% increase, the largest jump in eight years. This growth highlights the need for strategic approaches in every part of the drug development lifecycle.

This growth is reflected in the latest rankings, with oncology remaining the top therapeutic area by a significant margin. Meanwhile, Metabolic/endocrinology widened its lead over infectious diseases. Among top sponsors, Merck & Co. led the way, with Pfizer, AstraZeneca, Bristol Myers Squibb, and Roche rounding out the top five for completed trials in 2024. This collection of data highlights the importance of strategic biostatistics in navigating these dynamic shifts and driving success in the evolving research landscape.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader